The best light therapy option for sundowning is bright light therapy using a 10,000-lux, full-spectrum, UV-free light box for about 30 minutes each morning. This approach, backed by a 2022 systematic review in the Journal of Alzheimer’s Disease Reports, has been shown to significantly reduce sundowning behaviors — the agitation, confusion, and anxiety that tend to flare up in the late afternoon and evening for people living with dementia. Products like the Verilux HappyLight Liberty (around $99.95) and the Carex Day-Light Bright Light Therapy Lamp are specifically designed to deliver this kind of therapeutic light exposure, and both meet the clinical benchmarks most commonly referenced in the research.
That said, the picture is not as clean-cut as some caregiving websites suggest. A 2024 systematic review published in Neurology Asia found that bright light therapy had no statistically significant effect on sundowning behavior specifically, even though sleep improvements were consistent across studies. The Alzheimer’s Society in the UK has also stopped short of a full endorsement, stating that “more evidence is needed before we can recommend using light therapy to help treat dementia and its symptoms.” What the evidence does strongly support is that light therapy improves sleep quality and reduces nighttime awakenings — which, for many caregivers dealing with sundowning, is reason enough to try it. This article covers how bright light therapy works, emerging alternatives like red and near-infrared light, specific product recommendations, safety concerns, and how to combine light therapy with other non-drug strategies.
Table of Contents
- How Does Bright Light Therapy Help With Sundowning in Dementia Patients?
- What the Research Actually Shows — And Where the Evidence Falls Short
- Red and Near-Infrared Light Therapy — An Emerging Alternative
- Choosing a Light Therapy Lamp — What to Look for and How Products Compare
- Safety Concerns and When Light Therapy Is Not Appropriate
- Combining Light Therapy With Other Non-Drug Approaches
- Where Light Therapy Research Is Heading
- Conclusion
- Frequently Asked Questions
How Does Bright Light Therapy Help With Sundowning in Dementia Patients?
Sundowning affects between 20 and 45 percent of Alzheimer’s patients, with some studies putting the number above 60 percent depending on the diagnostic criteria used. In one study of 184 dementia patients, 21.2 percent exhibited sundowning, with the most common expressions being agitation (56.4 percent), irritability (53.8 percent), and anxiety (46.2 percent). These symptoms tend to emerge in the late afternoon or early evening and are thought to be driven, at least in part, by disruptions to the circadian rhythm — the internal clock that tells us when to sleep and when to be awake. Bright light therapy works by resetting that internal clock. When a person sits near a 10,000-lux light box for around 30 minutes, the light signals the brain’s suprachiasmatic nucleus to recalibrate its sense of day and night.
The standard protocol calls for the light box to be positioned 16 to 24 inches from the face, ideally during morning hours. Morning sessions have been shown to improve nighttime sleep, increase daytime wakefulness, and reduce evening agitation — which directly targets the window when sundowning hits hardest. For dementia patients who are most alert at midday rather than morning, midday sessions may actually be more effective, so caregivers should observe when their loved one is most receptive before locking in a schedule. A 2023 meta-analysis of 11 randomized controlled trials found that light therapy contributed to a measurable reduction in behavioral disturbances among dementia patients. However, it is worth noting that “behavioral disturbances” is a broad category, and the specific impact on sundowning as a distinct phenomenon remains debated. The strongest and most replicated finding is that bright light therapy significantly reduces nighttime awakenings and enhances overall sleep quality — which, in practice, often translates to fewer sundowning episodes because a better-rested person is less prone to late-day agitation.
What the Research Actually Shows — And Where the Evidence Falls Short
The enthusiasm around light therapy for sundowning is understandable, but caregivers deserve an honest look at what the science does and does not support. The 2022 systematic review in the Journal of Alzheimer’s Disease Reports did find significant reductions in sundowning behaviors with bright light therapy. And the 2023 meta-analysis of 11 RCTs confirmed reductions in behavioral disturbances more broadly. These are encouraging findings. However, the 2024 systematic review published in Neurology Asia tells a more cautious story.
That review found bright light therapy had no statistically significant effect on sundowning behavior specifically, even though the sleep-related benefits were consistent. This discrepancy likely comes down to how different studies define and measure sundowning — some lump it in with general agitation, while others try to isolate it as a time-of-day-specific phenomenon. The Alzheimer’s Society in the UK reflects this uncertainty, acknowledging that while the therapy shows promise, the evidence base is not yet strong enough for a blanket recommendation. What does this mean for caregivers? If your primary goal is to reduce nighttime awakenings and improve sleep quality in someone with dementia, the evidence for bright light therapy is solid. If your goal is specifically to eliminate late-afternoon agitation and confusion, light therapy may help — and many caregivers report that it does — but you should go in with realistic expectations. It is not a guaranteed fix for sundowning, and it works best as part of a broader strategy rather than a standalone intervention.
Red and Near-Infrared Light Therapy — An Emerging Alternative
Beyond traditional bright light boxes, there is growing interest in red and near-infrared light therapy, also known as photobiomodulation. Unlike bright white light therapy, which works by resetting circadian rhythms through the eyes, photobiomodulation uses specific wavelengths of light that penetrate the skin and skull to directly stimulate cellular activity in the brain. Early research has shown encouraging signs: increased cognitive function, reduced anxiety, less wandering, and better sleep in Alzheimer’s patients. One specific parameter gaining attention is 40 Hz flickering light, which some researchers and care providers cite as a beneficial frequency for people experiencing sundowning. The theory is that 40 Hz stimulation may help entrain gamma brain waves, which are associated with attention and cognitive processing and tend to be disrupted in Alzheimer’s disease.
This is still very much an emerging field, and the studies so far have been small. But the fact that photobiomodulation targets different mechanisms than traditional bright light therapy means the two approaches are not mutually exclusive — a caregiver could potentially use a standard 10,000-lux light box in the morning and explore red or near-infrared light as a complement, though this should be discussed with a healthcare provider first. The critical difference between the two options is the strength of the evidence. Bright light therapy has decades of research behind it, including multiple randomized controlled trials and systematic reviews. Red and near-infrared therapy for dementia is still in the early stages, with mostly small pilot studies and case reports. It is promising, but caregivers should not treat it as a proven alternative to bright light therapy just yet.
Choosing a Light Therapy Lamp — What to Look for and How Products Compare
When shopping for a light therapy device, three specifications matter most: 10,000-lux output, UV-free design, and full-spectrum light. A lamp that falls short on any of these may not deliver enough therapeutic benefit or could pose risks to sensitive eyes and skin. Two products that consistently appear in recommendations for dementia caregivers are the Verilux HappyLight Liberty, which delivers 10,000 lux and retails for approximately $99.95, and the Carex Day-Light Bright Light Therapy Lamp, which also reaches up to 10,000 lux and was designed specifically with sundowning syndrome in mind. The Verilux HappyLight Liberty is compact and relatively affordable, making it a reasonable starting point for families who want to test whether light therapy helps before committing to a larger investment. The Carex Day-Light, on the other hand, has a larger surface area, which means the light is more evenly distributed across the face and the user does not need to sit quite as close to it.
For a dementia patient who may not sit perfectly still or who resists having objects placed close to their face, the Carex model may be the more practical choice despite a higher price point. One tradeoff to consider is portability versus coverage. Smaller lamps are easier to move from room to room and store when not in use, but they require the user to sit closer — within that 16-to-24-inch range — for the full 30 minutes. Larger lamps allow more flexibility in positioning but take up more space. For someone in a care facility, check whether the staff are willing to set up and supervise daily sessions, because consistency matters more than which specific lamp you buy.
Safety Concerns and When Light Therapy Is Not Appropriate
Light therapy is non-pharmacological and non-invasive, which is a major reason it has gained traction as a preferred first-line option before medication for sundowning. The Cleveland Clinic lists it among recommended non-drug approaches for sundown syndrome. But “non-invasive” does not mean “risk-free for everyone.” The most important contraindication is macular degeneration. Patients with existing retinal damage or degenerative eye conditions can be harmed by prolonged exposure to intense light, even if the lamp is UV-free. Light-sensitive mood disorders are another concern — in rare cases, bright light therapy can trigger manic episodes in people with bipolar disorder, which can coexist with dementia.
Any caregiver considering light therapy should consult a healthcare provider first, particularly if the person with dementia has a history of eye problems or psychiatric conditions beyond their dementia diagnosis. There are also practical safety issues. A person with moderate to advanced dementia may not understand why a bright light is shining at them and could become agitated rather than soothed. Starting with shorter sessions of 10 to 15 minutes and gradually working up to 30 minutes can help, as can positioning the light during a calm activity like eating breakfast or listening to music. If light therapy consistently increases agitation rather than reducing it, that is a signal to stop and discuss alternatives with a doctor — not to push through in hopes it will eventually work.
Combining Light Therapy With Other Non-Drug Approaches
A January 2026 article from The Greens at Greenwich recommends combining light therapy with art therapy during winter months to combat sundowning, noting that reduced natural daylight in winter exacerbates symptoms. This is a practical insight that many caregivers overlook — sundowning often worsens seasonally, and a light therapy routine that works well in June may not be sufficient in December when natural light exposure drops dramatically.
Beyond art therapy, other complementary strategies include maintaining a consistent daily routine, reducing caffeine and sugar intake in the afternoon, keeping the home well-lit as evening approaches rather than letting rooms grow dim, and encouraging physical activity earlier in the day. Light therapy is most effective when it is part of a structured daily rhythm rather than the only intervention. Think of it as one anchor in a broader routine designed to give the brain consistent cues about what time of day it is.
Where Light Therapy Research Is Heading
The next few years are likely to bring more clarity on several open questions. The gap between the 2022 and 2024 systematic reviews — one finding significant benefits for sundowning and the other finding no statistically significant effect — highlights the need for larger, more standardized trials that measure sundowning as a specific outcome rather than lumping it in with general behavioral disturbances. Researchers are also beginning to explore whether combining bright light therapy with red or near-infrared photobiomodulation produces additive benefits, and whether personalized timing protocols based on individual circadian patterns could improve outcomes.
For now, light therapy remains one of the most accessible and low-risk tools available to caregivers dealing with sundowning. It will not work for everyone, and it is not a cure. But for a condition that has no reliable pharmaceutical treatment, a strategy that consistently improves sleep and shows strong signals for reducing agitation is worth trying — with appropriate medical guidance and realistic expectations.
Conclusion
Bright light therapy using a 10,000-lux, UV-free, full-spectrum light box remains the best-supported light therapy option for managing sundowning in dementia patients. The standard protocol of 30 minutes daily, ideally in the morning, has strong evidence for improving sleep quality and reducing nighttime awakenings, with promising — though not yet definitive — evidence for reducing sundowning-specific agitation and confusion. Emerging options like red and near-infrared photobiomodulation add an interesting dimension, but they are not yet backed by the same depth of research.
Caregivers should start by consulting a healthcare provider to rule out contraindications like macular degeneration, then select a lamp that meets the 10,000-lux and UV-free benchmarks, and commit to consistent daily sessions for at least several weeks before evaluating results. Combining light therapy with other non-drug strategies — structured routines, afternoon light management, complementary therapies like art — gives the best chance of meaningful improvement. The research continues to evolve, but the current evidence already makes a reasonable case for trying light therapy as a first-line, non-pharmacological approach to a condition that affects millions of families.
Frequently Asked Questions
How long does it take for light therapy to reduce sundowning symptoms?
Most clinical trials assess outcomes after two to four weeks of consistent daily use. Some caregivers report noticing improved sleep within the first week, but reductions in late-afternoon agitation may take longer. Consistency matters more than duration of any single session.
What time of day should light therapy be used for sundowning?
Morning sessions are the most commonly recommended, as they help reset the circadian clock and promote nighttime sleepiness. However, for dementia patients who are most alert and cooperative at midday, midday sessions may be more practical and still effective.
Can light therapy replace medications for sundowning?
Light therapy is considered a first-line non-pharmacological option, and the Cleveland Clinic recommends trying non-drug approaches before medication. However, it is not a replacement for medication in all cases — some patients may need both. This is a conversation to have with a physician.
Is it safe to use a light therapy lamp every day?
For most people, daily use is safe and is in fact how the therapy is designed to work. The main exceptions are patients with macular degeneration, certain retinal conditions, or light-sensitive mood disorders. Always check with a healthcare provider before starting.
Does insurance cover light therapy lamps for dementia patients?
Coverage varies widely. Some insurance plans and Medicare Advantage plans may cover light therapy devices with a physician’s prescription, but many do not. At around $100 for an entry-level 10,000-lux lamp, the out-of-pocket cost is relatively low compared to most medical interventions.
